New patent for Teva Pharms drug ALVAIZ
Annual Drug Patent Expirations for ALVAIZ Alvaiz is a drug marketed by Teva Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for ALVAIZ Alvaiz is a drug marketed by Teva Pharms Inc and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for SELENIOUS+ACID Selenious Acid is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. The generic ingredient…
Source
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents…
Source
Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are two patents…
Source
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies…
Source
Crucial Insights on Patent Litigation Strategies in Pharma Industry Read Post »
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers. There are eleven patents protecting…
Source
New patent expiration for Bristol-myers drug ABRAXANE Read Post »
This chart shows the patent expirations for solution dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
Source
Annual Drug Patent Expirations for ILEVRO Ilevro is a drug marketed by Harrow Eye and is included in one NDA. It is available from two suppliers. There are three patents…
Source
New patent expiration for Harrow Eye drug ILEVRO Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Norway. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Norway? Read Post »
Get new actionable insights and updates from BiotechBlog